XML 40 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Basis of Presentation and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Aug. 21, 2020
Aug. 21, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Aug. 18, 2020
Significant Accounting Policies [Line Items]            
Common stock, par value     $ 0.02   $ .02  
Number of newly issued shares        
Impairment of goodwill       $ 685,000    
Customer One [Member] | Sales Revenue, Goods, Net [Member]            
Significant Accounting Policies [Line Items]            
Concentration of credit risk, percentage     40.00% 39.00%    
Customer One [Member] | Accounts Receivable [Member]            
Significant Accounting Policies [Line Items]            
Concentration of credit risk, percentage     65.00% 59.00%    
Customer Two [Member] | Sales Revenue, Goods, Net [Member]            
Significant Accounting Policies [Line Items]            
Concentration of credit risk, percentage     40.00% 39.00%    
Customer Two [Member] | Accounts Receivable [Member]            
Significant Accounting Policies [Line Items]            
Concentration of credit risk, percentage     65.00% 59.00%    
HWH Korea [Member]            
Significant Accounting Policies [Line Items]            
Shares issued under the term of share exchange     127,179,000      
Due from related party     $ 246,000   $ 1,100,000  
Periodic fee remittance percentage     2.50%      
Remitted amount, net of fees and other expenses     $ 912,000      
HWH Korea [Member] | Other Current Liabilities [Member]            
Significant Accounting Policies [Line Items]            
Due from related party     $ 246,000      
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]            
Significant Accounting Policies [Line Items]            
Equity ownership percentage           19.99%
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member]            
Significant Accounting Policies [Line Items]            
Equity ownership percentage 100.00% 100.00%        
Shares issued under the term of share exchange 483,334          
Common stock, par value $ 0.02 $ 0.02        
Shares issued price per share 6.48 $ 6.48        
Number of newly issued shares   483,334        
Impact BioMedical, Inc. [Member] | Share Exchange Agreement [Member] | Series A Convertible Preferred Stock [Member]            
Significant Accounting Policies [Line Items]            
Shares issued price per share $ 1,000 $ 1,000        
Number of newly issued shares 46,868